Related Experiment Video
Updated: Jul 31, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
The prognostic role of right ventricular dysfunction in patients with hypertrophic cardiomyopathy
Saima Mushtaq1, Lorenzo Monti2,3, Alexia Rossi2,3
1Department of Cardiovascular Imaging, Centro Cardiologico Monzino, IRCCS, Via C. Parea 4, 20138, Milan, Italy.
Insights
Right ventricular (RV) abnormalities detected by cardiac magnetic resonance (CMR) imaging can predict major adverse cardiac events (MACE) in patients with hypertrophic cardiomyopathy (HCM). These RV findings, along with left atrium diameter, are crucial for prognostic assessment in HCM.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is typically characterized by left ventricular (LV) hypertrophy.
- However, right ventricular (RV) involvement, including hypertrophy and functional changes, is increasingly recognized in HCM patients.
- Cardiac magnetic resonance (CMR) is a key imaging modality for assessing cardiac structure and function.
Purpose of the Study:
- To evaluate RV size and function in a large cohort of HCM patients using CMR.
- To determine if RV parameters, in conjunction with other CMR findings, can predict major adverse cardiac events (MACE).
Main Methods:
- A prospective cohort study involving 315 HCM patients from two centers (2011-2017).
- CMR studies were performed to assess LV and RV size, function, and myocardial late gadolinium enhancement (LGE).
- MACE included ventricular arrhythmias, heart failure hospitalization, and cardiac death, with a mean follow-up of 65 months.
Main Results:
- Patients who experienced MACE had significantly larger left atrium diameter, increased LV mass, and more myocardial LGE compared to those without events.
- MACE patients also exhibited lower RV stroke volume index, higher prevalence of RV hypertrophy, and reduced RV ejection fraction.
- Multivariate analysis identified left atrium diameter and RV stroke volume index as the strongest predictors of MACE.
Conclusions:
- Anatomic and functional RV anomalies detected by CMR play a significant role in predicting prognosis for HCM patients.
- RV assessment using CMR should be integrated into the risk stratification of individuals with HCM.
- These findings highlight the importance of evaluating both ventricles in HCM for comprehensive risk assessment.
Abstract:
Hypertrophic cardiomyopathy (HCM) primarily affects the left ventricle (LV) sparing the right ventricle (RV) in vast majority of cases. However, several studies employing CMR have revealed that myocardial hypertrophy may also involve the RV. To assess RV size and function in a large prospectively cohort of HCM patients and to evaluate whether these parameters in association with other MR findings can predict cardiac events. Two participating centers prospectively included patients with known or suspected HCM between 2011 and 2017. CMR studies were performed with three different scanners. Outcome measures were a composite of ventricular arrhythmias, hospitalization for HF and cardiac death. Of 607 consecutive patients with known or suspected HCM, 315 had complete follow-up information (mean 65 ± 20 months). Among them, 115 patients developed major cardiac events (MACE) during follow-up. At CMR evaluation, patients with events had higher left atrium (LA) diameter (41.5 ± 8 mm vs. 37.17 ± 7.6 mm, p < 0.0001), LV mass (156.7 vs. 144 g, p = 0.005) and myocardial LGE (4.3% vs. 1.9%, p = 0.001). Similarly, patients with events had lower RV stroke volume index (42.7 vs. 47.0, p = 0.0003) and higher prevalence of both RV hypertrophy (16.4% vs. 4.7%, p = 0.0005) and reduced RV ejection fraction (12.2% vs. 4.4%, p = 0.006). In the multivariate analysis, LA diameter and RV stroke volume index were the strongest predictors of events (p < 0.001 and p = 0.0006, respectively). Anatomic and functional RV anomalies detected and characterized with CMR may have may have a major role in predicting the prognosis of HCM patients.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis I: Introduction

